Sagimet Biosciences Inc
Price
FilingsNewest: 8-K, Material agreementSep 30 →InsidersNo open-market buys. 5 insiders sold $395,279, 1 of 5 sales on a 10b5-1 plan.→HoldersBlackRock $50.8MBalyasny $28.0MWoodline Partners $23.2M→Financing →PeersClosest companies: GLUE, BHVN, VKTX→
From the filings
Figures
- Net income
- −$47.1Mlast 12 months
- Operating cash flow
- −$39.7Mlast 12 months
- Cash and equivalents
- $165.9Mat the last balance sheet